FTIOP
ARRY

Fiduciary Trust International of Pennsylvania’s Array Biopharma Inc ARRY Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,500
Closed -$301K – 384
2019
Q2 		$301K Buy
+6,500
New +$183K 0.01% 335
2015
Q1 		– Sell
-10,000
Closed -$47K – 363
2014
Q4 		$47K Hold
10,000
– – ﹤0.01% 355
2014
Q3 		$36K Hold
10,000
– – ﹤0.01% 352
2014
Q2 		$46K Hold
10,000
– – ﹤0.01% 351
2014
Q1 		$47K Hold
10,000
– – ﹤0.01% 340
2013
Q4 		$50K Hold
10,000
– – ﹤0.01% 329
2013
Q3 		$62K Hold
10,000
– – 0.01% 318
2013
Q2 		$45K Buy
+10,000
New +$53.8K ﹤0.01% 309

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's ARRY Position: Q3 2019 in Review

Fiduciary Trust International of Pennsylvania sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 6,500 shares — an estimated $301K sold.

Fiduciary Trust International of Pennsylvania first reported a position in ARRY in Q2 2013 and held it in 8 quarters. The position peaked at $301K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Fiduciary Trust International of Pennsylvania reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Fiduciary Trust International of Pennsylvania sold 6,500 Array Biopharma Inc shares in Q3 2019, an estimated $301K.
  • Fiduciary Trust International of Pennsylvania first reported a position in Array Biopharma Inc in Q2 2013 and held it in 8 quarters.
  • Fiduciary Trust International of Pennsylvania's Array Biopharma Inc position peaked at $301K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q3 2019, filed 9 Oct 2019.